"Current options and principles of pathomorphology-based tummour diagnostics"@en . "Pov\u00FD\u0161il, Ctibor" . "0042-773X" . "288754" . . "RIV/00064165:_____/10:8172!RIV11-MZ0-00064165" . . . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . "56" . "Sou\u010Dasn\u00E9 mo\u017Enosti a principy patomorfologick\u00E9 diagnostiky n\u00E1dor\u016F"@cs . . . "Sou\u010Dasn\u00E9 mo\u017Enosti a principy patomorfologick\u00E9 diagnostiky n\u00E1dor\u016F"@cs . . . . "6"^^ . "The most difficult task for a pathologis is defining the primary focus of the tumour in cases where only a faction of a metastasis is available for examination. Nevertheless, at present, it is feasible to tract the tumour differentiation down and, using antibody battery, parcicularly against specific cytokerines and vimentine and including organ-specific markert, to identify the primary source or at least to establish an assumption about the most likely organ affected by the tumour process."@en . . "N" . . "Sou\u010Dasn\u00E9 mo\u017Enosti a principy patomorfologick\u00E9 diagnostiky n\u00E1dor\u016F" . "7" . "1"^^ . "Current options and principles of pathomorphology-based tummour diagnostics"@en . "RIV/00064165:_____/10:8172" . "pathomorphology; tumours; diagnostics; modern methods"@en . . . "CZ - \u010Cesk\u00E1 republika" . "1"^^ . "Neobt\u00ED\u017En\u011Bj\u0161\u00EDm \u00FAkolem pro patologa je ur\u010Den\u00ED prim\u00E1rn\u00EDho v\u00FDchodiska n\u00E1doru v p\u0159\u00EDpadech, kdy m\u00E1 k dispozici pouze vzorek z metast\u00E1zy. I v t\u011Bchto p\u0159\u00EDpadech v\u0161ak lze v dne\u0161n\u00ED dob\u011B identifikovat linii diference n\u00E1doru a za pomoci panelu protil\u00E1tek p\u0159edev\u0161\u00EDm proti specifick\u00FDm cytokeratin\u016Fm a vimentinu v\u010Detn\u011B pou\u017Eit\u00ED org\u00E1nov\u011B specifick\u00FDch marker\u016F pak ur\u010Dit prim\u00E1rn\u00ED zdroj nebo aspo\u0148 s vysokou m\u00EDrou pravd\u011Bpodobnosti vyslovit podez\u0159en\u00ED na p\u0159\u00EDtomnost n\u00E1dorov\u00E9ho procesu v konkr\u00E9tn\u00EDm org\u00E1nu." . "Sou\u010Dasn\u00E9 mo\u017Enosti a principy patomorfologick\u00E9 diagnostiky n\u00E1dor\u016F" . . . . "[BF0065E5AE13]" . "Neobt\u00ED\u017En\u011Bj\u0161\u00EDm \u00FAkolem pro patologa je ur\u010Den\u00ED prim\u00E1rn\u00EDho v\u00FDchodiska n\u00E1doru v p\u0159\u00EDpadech, kdy m\u00E1 k dispozici pouze vzorek z metast\u00E1zy. I v t\u011Bchto p\u0159\u00EDpadech v\u0161ak lze v dne\u0161n\u00ED dob\u011B identifikovat linii diference n\u00E1doru a za pomoci panelu protil\u00E1tek p\u0159edev\u0161\u00EDm proti specifick\u00FDm cytokeratin\u016Fm a vimentinu v\u010Detn\u011B pou\u017Eit\u00ED org\u00E1nov\u011B specifick\u00FDch marker\u016F pak ur\u010Dit prim\u00E1rn\u00ED zdroj nebo aspo\u0148 s vysokou m\u00EDrou pravd\u011Bpodobnosti vyslovit podez\u0159en\u00ED na p\u0159\u00EDtomnost n\u00E1dorov\u00E9ho procesu v konkr\u00E9tn\u00EDm org\u00E1nu."@cs .